Explained herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive prescription drugs, these types of programs together with a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with incredibly low permeability to